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Abstract
Background: Endothelial cells are of great interest for cell therapy and tissue engineering. Understanding the heterogeneity
among cell lines originating from different sources and culture protocols may allow more standardized material to be
obtained. In a recent paper, we showed that adrenalectomy interferes with the expression of membrane adhesion
molecules on endothelial cells maintained in culture for 16 to 18 days. In addition, the pineal hormone, melatonin, reduces
the adhesion of neutrophils to post-capillary veins in rats. Here, we evaluated whether the reactivity of cultured endothelial
cells maintained for more than two weeks in culture is inversely correlated to plasma melatonin concentration.
Methodology/Principal Findings: The nocturnal levels of melatonin were manipulated by treating rats with LPS. Nocturnal
plasma melatonin, significantly reduced two hours after LPS treatment, returned to control levels after six hours. Endothelial cells
obtained from animals that had lower nocturnal melatonin levels significantly express enhanced adhesion molecules and iNOS,
and have more leukocytes adhered than cells from animals that had normal nocturnal levels of melatonin (naı ¨ve or injected with
vehicle). Endothelial cells from animals sacrificed two hours after a simultaneous injection of LPS and melatonin present similar
phenotype and function than those obtained from control animals. Analyzing together all the data, taking into account the plasma
melatonin concentration versus the expression of adhesion molecules or iNOS we detected a significant inverse correlation.
Conclusions/Significance: Our data strongly suggest that the plasma melatonin level primes endothelial cells ‘‘in vivo,’’
indicating that the state of the donor animal is translated to cells in culture and therefore, should be considered for
establishing cell banks in ideal conditions.
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Introduction
Endothelial cells are located on the internal vascular layer and
are responsible for modulating vascular tone and leukocyte
migration. They are of great interest to cell therapy and tissue
engineering. The heterogeneity among cells originated from
different sources and culture protocols needs to be understood in
order to obtain more standardized material to avoid rejection due
to uncontrolled migration of immune competent cells [1].
Endothelial cells are known to be preconditioned ‘‘in vitro’’.
Treatment with low concentrations of lipopolysaccharide (LPS) or
tumor necrosis factor (TNF) [2], and short periods of ischemia-
reperfusion (I/R) [3] protect the cells against subsequent harmful
injuries. LPS activates the nuclear factor kappa B (NFKB)
pathway, which leads to the expression of inducible nitric oxide
synthase (iNOS) [4]. Melatonin, the indoleamine derived from
serotonin and released at night by the pineal gland, inhibits LPS-
induced iNOS expression [4] and leukocyte-endothelial interac-
tion [5,6]. The short and long-term effects of melatonin are due to
modulation of calcium metabolism [7], and inhibition of the
NFKB pathway [4], respectively.
During the last decades, many works showed the immune
properties of melatonin, and more recently, we suggested the
existence of an immune-pineal axis [8]. In such context, LPS and
the inflammatory cytokine TNF, produced at the beginning of an
inflammatory response, inhibits pineal gland nocturnal melatonin
production [9,10], which is restored by corticosterone [11]. Taking
into account that melatonin inhibits the rolling and adhesion of
leukocytes to endothelial cells [5], the reduction in plasma
melatonin levels favors the migration of cells to the site of a lesion.
A similar role is exerted by glucocorticoids, as adrenalectomy or
inhibition of corticosterone synthesis also result in an increase in
leukocyte rolling and adhesion to post-capillary veins [12].
Cultures of endothelial cells obtained from adrenalectomized
rats adhere significantly more neutrophils than those obtained
from sham operated or naı ¨ve rats [13], indicating that these cells
could be primed by ‘‘in vivo’’ conditions. Taking into account that
a lack of adrenal glands is not a common condition, we looked for
other models that could prime endothelial cells.
The present work aimed to evaluate whether plasma melatonin
level could interfere in the reactivity of endothelial cells cultured
up to 16–18 days. The pineal gland is an integral part of the innate
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e13958immune response, as the production of melatonin is suppressed in
order to allow a full migration of neutrophils independently of the
hour of the day [8]. Thus, we injected LPS in order to reduce
nocturnal melatonin surge. As a negative control, rats were
injected with LPS plus melatonin. We measured the adhesion of
leukocytes to primed endothelial cells, as well as the expression of
molecules related to endothelium activation, such as adhesion
molecules and iNOS. The inverse correlation between plasma
melatonin level and the reactivity of endothelial cells strongly
suggest a priming of the cells by the status of the donor at the
moment of death.
Materials and Methods
Adult Wistar rats (300–330 g), housed under 12/12 h light/
dark cycle (lights on at 06h00), were divided into four groups:
naı ¨ve, vehicle (saline +5% ethanol), LPS (0.5 mg/kg; Sigma) and
LPS + melatonin (3 mg/kg; Sigma). All rats were killed six hours
after lights off, which represent the maximal plasma melatonin
concentration [11]. LPS injection (intravenous – caudal vein) was
done two or six hours before decapitation (Fig. 1), in order to
coincide with the TNF plasma peak (two hours) and with the
return to basal levels (six hours) [14].
All experiments were carried out in compliance with ethical
standards of our institution (Ethic Committee of the Institute of
Bioscience of the University of Sa ˜o Paulo license 086/2008) and
with the recommendations of the National Council on Experi-
mental Animal Control (CONCEA).
Melatonin assay
Plasma melatonin was assayed using an ELISA kit with a
detection limit of 3.0 pg/mL (GenWay Biotech Inc., CA, USA).
The plates were read in a microplate spectrophotometer
(SpectraMAX 250, Molecular Devices, CA, USA) at 405 nm.
Endothelial cell culture
Primary cultures of endothelial cells were obtained from rat
cremaster muscle according to the method described previously
[15]. The cremaster was isolated, washed with phosphate saline
solution (PSS; mM: NaCl 125.0, Na2HPO4 2.0, NaH2PO4 2.0 and
KCl 5.0) and cut intopieces of approximately 262 mm. Twopieces
per well were placed into a 24-well culture plate with Dulbecco’s
Figure 1. Experimental protocols. Wistar rats were divided into four
groups: naı ¨ve, vehicle, lipopolysaccharide (LPS, 0.5 mg/kg) and LPS +
melatonin (MEL 3 mg/kg). The intravenous (caudal vein) injections of
vehicle, LPS or LPS + melatonin were performed two (A) or six (B) hours
before sacrifice (6 hours after lights off –24h00). Grey portion represents
the dark phase of the day.
doi:10.1371/journal.pone.0013958.g001
Figure 2. Standard curve of leukocyte adhesion assay. Representative image of experimental myeloperoxidase assay (A). The number of
polymorphonuclear cells (PMN) was determined by comparison with standard curve (B). Confluent endothelial cell culture adhered (D) or not (C) with
leukocytes. Arrow indicates leukocytes adhered to endothelial cells. Scale bar =50 mm.
doi:10.1371/journal.pone.0013958.g002
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L, Gibco) and fetal bovine serum (20%, Gibco). The explants were
maintained in a humidified incubator (37uC, 5% CO2). After 48 h
the explants were removed, the cells were cultured till confluence
(14–16 days), and the medium was changed every 48 h.
Immunofluorescence
Protein detection by immunofluorescence was based on Tamura
et al. [4]. Endothelial cells were subcultured for 48 h in chamber
slides (8 wells, 10
4 cells/well), fixed in methanol/acetone (1:1,
15 min, 220uC) and incubated with antibodies for ICAM-1 or
PECAM-1 (1:100) for 20 min (FITC-conjugated mouse anti-rat
ICAM-1; intercellular adhesion molecule 1; PE-conjugated mouse
anti-rat PECAM-1; platelet endothelial cell adhesion molecule 1;
BD Pharmingen), or permeabilized for 30 min (room temperature)
withTritonX-100(0.2%)andincubatedovernight(4uC)withiNOS
antibody (1:50, TRITC-conjugated polyclonal rabbit anti-iNOS
Santa Cruz Biotechnology). FITC and PE were excited at 488 nm
(Argon laser) and 543 nm (HeNe laser) and emitted fluorescence
was measured at 515–530 and 560–575 nm, respectively. TRITC
was excited at 543 nm and emitted fluorescence at 514 nm. Slides
mounted in glycerol/PSS solution (1:1) were visualized by confocal
microscopy (LSM 510; Carl Zeiss, Jena, Germany). Three fields
with 4–6 cells were randomly chosen and imaged.
Leukocyte-endothelial cell adhesion assay
The adhesion assay was performed according to Lotufo et al.
[6]. Endothelial cells (10
4 cells/well) from different groups were
seeded in 96-well plates and allowed to grow till confluence, which
was reached after 5 days.
For each experimental group, one well of endothelial cells was
kept without polymorphonuclear cells (PMN). At the end of the
experimental protocol we counted the number of endothelial cells
in these wells, which was used to normalize the amount of PMN
adhered. This procedure was important, because the amount of
endothelial cells after reaching confluence could be different in
each experimental group.
At the day of the experiment, endothelial cells, washed with
Hank’s balanced salt solution, were incubated for 30 min with
PMN (5610
4 cells/well) obtained from rat aorta blood. Non-
adherent PMN were washed and myeloperoxidase colorimetric
assay was applied to detect the PMN adhered to the endothelial
cells layer, using tetrametylbenzidine (TMB; Sigma) as the
peroxidase substrate. Cells were incubated at room temperature
for 5 min with 0.25% of dodecyltrimethylammonium bromide as
a peroxidase solubilizer and TMB (5,3 mM) dissolved in sodium
acetate buffer (0.05 M, pH 5.8). In sequence, hydrogen peroxidase
(100 mL, 2.5 mM) was incubated for exactly 2 min, and the
reaction was stopped with sulfuric acid (50 mL, 1 M). The
absorbance was determined using a microplate spectrophotometer
(spectraMAX 250, Molecular Devices, CA, USA) at 420 nm. The
quantification of PMN adhesion was based on a standard curve
obtained with known amounts of PMN. The number of adhered
cells was calculated from the one-phase association equation
obtained from the standard curve using Graphpad Prism Software
(4.0; CA, USA) (Fig. 2).
Figure 3. Nocturnal plasma melatonin levels vary during the
development of response against lipopolysaccharide challenge.
Plasma melatonin from naı ¨ve (black bar), vehicle injected (white bars),
lipopolysaccharide injected (LPS, 0.5 mg/kg; grey bars) or LPS plus
melatonin injected (3 mg/kg; grey diagonal striped bars) animals was
determined by ELISA. The injections were performed 2 or 6 hours before
sacrifice (6 hours after lights off –24 h 00). Data are expressed as mean 6
SEM, n=4–8 per group of at least two different experiments; * signifi-
cantly different (P,0.05) versus naı ¨ve group (black bar); # significantly
different (P,0.05) versus the 2 hours vehicle group (white bars).
doi:10.1371/journal.pone.0013958.g003
Figure 4. Melatonin regulates leukocyte adhesion to cultured
endothelial cells. Leukocyte adhesion on endothelial cells cultures
obtained from naı ¨ve (black bar), vehicle injected (white bars),
lipopolysaccharide injected (LPS, 0.5 mg/kg; grey bars) or LPS +
melatonin injected (MEL 3.0 mg/kg; grey diagonal striped bars) animals
was determined by leukocyte-endothelial adhesion assay. The injec-
tions were performed 2 or 6 hours before sacrifice (6 hours after lights
off –24 h 00). Data are expressed as mean 6 SEM, n=4–8 per group of
at least two different experiments; * significantly different (P,0.05)
versus 2 hours vehicle group (white bars).
doi:10.1371/journal.pone.0013958.g004
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All the data are expressed as mean 6 S.E.M., and were
compared by Student’s t-test (two groups) or one-way ANOVA
followed by Newman-Keuls test (more than two groups). Linear
regression was tested by Analysis of Variance for detecting slopes
(expressed as mean 6 S.E.M.) different from zero, and correlation
between two parameters was tested according to Pearson’s
coefficient. Results were considered significantly different when
P,0.05. Plasma melatonin is shown as pg/mL and the other
results as percentage of naı ¨ve group, set as 100%.
Results
Plasma melatonin
Plasma melatonin concentration was significantly reduced after
two, but not after six hours of LPS injection when compared to the
vehicle (Fig. 3). A smaller, but significant, reduction in melatonin
was also observed when the group injected with vehicle (2 hours)
was compared to naı ¨ve group. Here, there was no difference after
six hours. The administration of 3 mg/kg of melatonin increased
the plasma concentration of melatonin to values much higher than
those determined at night.
Leukocytes adhesion
LPS injected two hours before sacrifice increased the adhesion
of leukocytes to endothelial cells in comparison to naı ¨ve and
vehicle groups. Conversely, six hours after LPS, no difference
between adherence in experimental and control groups were
observed. No difference between naı ¨ve and vehicle groups was
observed. Melatonin treatment inhibited the effect of LPS in the
group sacrificed two hours after treatment (Fig. 4).
iNOS expression
iNOS expression in endothelial cells from the LPS group injected
two hours before sacrifice was increased in comparison to naı ¨ve and
vehicle groups. On the other hand, six hours after LPS, no
differencewasobserved.Melatonininhibited theeffectofLPSinthe
group sacrificed two hours after treatment (Fig. 5 A, B, C; figure 6).
PECAM-1 and ICAM-1 expression
LPS administration two, but not six, hours before sacrifice
induced an increase in PECAM-1 (Fig. 5D, E and 7A) and ICAM-1
(Fig. 5G, H and 7B) expression when compared to control groups.
Melatoninimpaired LPS-induced increaseintheexpression ofthese
adhesion molecules (Fig. 5F and 5I). As occurred for the adhesion of
leukocytes and iNOS expression, no difference in PECAM-1 and
ICAM-1was observedsixhours afterLPSinjectionwhen compared
to control groups (Figs. 7A and 7B, respectively).
Correlation between plasma melatonin and the
expression of adhesion molecules and iNOS
The distribution of the data obtained by correlating the plasma
concentration of melatonin versus the expression of adhesion
molecules or iNOS, for each rat, followed linear regressions that
were significantly different from zero when tested by analysis of
Figure 5. Melatonin regulates the lipopolysaccharide-induced iNOS, PECAM-1 and ICAM-1 expression in endothelial cells.
Representative images of immunofluorescence assays of iNOS (A–C), PECAM-1 (D–F) and ICAM-1 (G–I). Columns show cells obtained from vehicle
(A, D and G), lipopolysaccharide (LPS) (B, E and H) and LPS + melatonin (MEL) (C, F and I) injected animals. Scale bar =50 mm.
doi:10.1371/journal.pone.0013958.g005
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PECAM-1, ICAM-1 and iNOS were 21.1360.48, 21.2560.44
and 20.9160.22, respectively. In addition, the Pearson’s coefficient
also point to an inverse correlation between the plasma concentra-
tion of melatonin and the expression of adhesion molecules
(PECAM-1 and ICAM-1) or iNOS (Pearson’s r=20.189,
20.477 and 20.692; confidence limits 20.763 to 20.146; 20.754
to 20.057 and 20.869 to 20.360; P,0.009, 0.029 and 0.0007).
Discussion
The increasing interest in applying cell therapy needs to be
preceded by improving the process of obtaining homogeneous and
reliable cell cultures. Endothelial cells, which form an interface
between blood and vascular tissue, regulate vascular tonus and
immune response. These cells can be obtained in a quiescent or
activatedstate,dependingonthehealthofthedonor.Intheactivated
state, cultured endothelial cells should have more leukocytes adhere
to them than quiescent cells, and their use in vascular grafts or tissue
engineering could be harmful for the recipient. We have previously
shown that melatonin reduces rolling and adhesion of leukocytes to
the post-capillary vein endothelial layer [5]. In the present paper, we
evaluated whether melatonin could have a protective effect against
LPS-induced priming of endothelial cells.
Here, for the first time, we demonstrate that endothelial cell
cultures obtained from LPS-treated animals have a higher ability
to adhere leukocytes than cultures obtained from naı ¨ve or vehicle
treated animals. This effect is strictly related to the time-course of
the innate immune response, as only cells derived from animals
killed two, but not six, hours after LPS were in an activated state,
since they exhibit a higher expression of adhesion molecules and
iNOS when compared to controls. It is interesting to note that the
‘‘in vitro’’ addition of LPS has a similar, but slower time-course
than that observed after ‘‘in vivo’’ priming. The incubation of
human umbilical vein endothelial cells (HUVEC) with LPS leads
to a maximal increase in leukocytes adhesion in four to six hours,
and even after 24 hours the cells are still activated [16].
Melatonin concentration in the plasma of donor animals was
reduced after two, but not six hours after LPS treatment, strongly
suggesting its relevance in the priming of endothelial cells. The
plasma TNF maximal peak in rats is supposed to occur two hours
after LPS treatment, while after six hours the level of TNF returns
to basal values [14]. The time-course of plasma melatonin
variation shown here reinforce a putative inhibition of pineal
Figure 6. Melatonin regulates the lipopolysaccharide-induced
iNOS expression in endothelial cells. iNOS expression in cultures
obtained from naı ¨ve (black bar), vehicle injected (white bars),
lipopolysaccharide injected (LPS, 0.5 mg/kg; grey bars) or LPS +
melatonin injected (MEL 3.0 mg/kg; grey diagonal striped bars) animals
was determined by confocal immunofluorescence. The injections were
performed 2 or 6 hours before sacrifice (6 hours after lights off –24h00).
Data are expressed as mean 6 SEM, n=4–8 per group; *significantly
different (P,0.05) versus 2 hours vehicle group (white bars).
doi:10.1371/journal.pone.0013958.g006
Figure 7. Melatonin regulates the lipopolysaccharide-induced PECAM-1 and ICAM-1 expression in endothelial cells. Expression of
PECAM-1 (A) and ICAM-1 (B) in cultures obtained from naı ¨ve (black bar), vehicle injected (white bars), lipopolysaccharide injected (LPS, 0.5 mg/kg;
grey bars) or LPS + melatonin injected (MEL 3.0 mg/kg; grey diagonal striped bars) animals were determined by confocal immunofluorescence. The
injections were performed 2 or 6 hours before sacrifice (6 hours after lights off –24h00). Data are expressed as mean 6 SEM, n=4–8 per group;
* significantly different (P,0.05) versus 2 hours vehicle group (white bars).
doi:10.1371/journal.pone.0013958.g007
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inhibits nocturnal melatonin production by activating toll-like
receptor 4 (TLR4) expressed in the pineal gland, and leading to a
local production of TNF [9]. The activation of LPS and TNF
receptors is transcribed by NFKB pathway [9]. This effect implies
in the reduction in nocturnal melatonin surge. Activation of
NFKB in the pineal gland inhibits the transcription of the key
enzyme in melatonin synthesis, arylalkylamine-N-acetyltransferase
[10,17]. Thus, LPS blocks nocturnal melatonin surge.
In order to confirm the role of melatonin in priming endothelial
cells, we tested the response of cells obtained from animals treated
with LPS plus melatonin. In this case, the state of the endothelial
cells was similar to that of the control, suggesting that the
reduction of melatonin by LPS was responsible for increasing
endothelial cell activity. However, the concentration of melatonin
attained in the plasma of animals injected with LPS plus melatonin
was much higher than that observed in the vehicle group.
In order to verify whether plasma melatonin concentration is in
fact the endogenous factor that translates LPS effect, we analyzed
the correlation between plasma melatonin concentration and the
expression of adhesion molecules and iNOS for each animal.
These results clearly show a significant inverse correlation, strongly
suggesting that melatonin primes endothelial cells regarding the
expression of adhesion molecules and iNOS.
The mechanism of action of melatonin could be related to the
inhibition of the NFKB pathway, which was shown in immune
competent cells [18], pineal gland [19] and in endothelial cells [4].
This pathway is known to result in epigenetic effects that could be
inherited independently from changes in the genome [20], which
would therefore, be maintained in long-term cultured cells.
In summary, this study evaluated the effect of melatonin in
priming endothelial cells. The LPS-induced reduction in plasma
melatonin levels is reflected in cultures that express higher amounts
of adhesion molecules and iNOS, and have more leukocytes
adhered than control cells. The restoration of plasma melatonin
concentration six hours after LPS, or at the simultaneous injection
ofLPSand melatonin(inordertoavoidthe initial plasma reduction)
leads to cultures with the same phenotype as the controls.
Therefore, the state of the donor animal primes the cells and
should be considered for establishing cell banks in ideal conditions.
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